Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models
- 30 June 2005
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 66 (2) , 99-102
- https://doi.org/10.1016/j.antiviral.2005.01.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Interferon Shows Promise in MonkeysScience, 2004
- Interferon-β 1a and SARS Coronavirus ReplicationEmerging Infectious Diseases, 2004
- Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory SyndromeJAMA, 2003
- Treatment of SARS with human interferonsThe Lancet, 2003
- SARS-Associated CoronavirusNew England Journal of Medicine, 2003
- Koch's postulates fulfilled for SARS virusNature, 2003
- VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASIONInternational Reviews of Immunology, 2002
- Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trialHepatology, 1997
- A Comparison of Interferon-Con1 with Natural Recombinant Interferons-α: Antiviral, Antiproliferative, and Natural Killer-Inducing ActivitiesJournal of Interferon Research, 1992
- NEW SIMPLE DYE-UPTAKE ASSAY FOR INTERFERON1981